CenterPoint Energy (CNP) Earnings Analysis

CenterPoint Energy (CNP) delivered mixed results in FY2026 on revenue of $39.9B versus the $39.5B estimate (-1.9% YoY) and EPS of $3.52. Below is the full CenterPoint Energy earnings breakdown — the risk-adjusted verdict, price forecast, technicals, options and hedge-fund 13F holdings, decoded in plain English.

CenterPoint Energy (CNP) Earnings Analysis — key stats

Next earnings dateJan 30, 2025
Latest reported quarterFY2026
Earnings verdictMixed
Revenue$39.9B (vs $39.5B est · +0.9% surprise · -1.9% YoY)
EPS$3.52 (vs $3.70 est · -4.9% surprise · +14.4% YoY)
Share price$386.66 (-1.9%)
Market cap$1.52T

What you'll find

Frequently asked questions

When is CenterPoint Energy's next earnings date?
CenterPoint Energy's (CNP) next scheduled earnings date is Jan 30, 2025. Magnisto shows the confirmed date, the options-implied expected move and the revenue and EPS estimates Wall Street is modeling into the report.
Did CenterPoint Energy (CNP) beat or miss earnings?
In FY2026, CenterPoint Energy (CNP) posted mixed results — revenue of $39.9B versus the $39.5B estimate (+0.9% surprise) and EPS of $3.52 versus $3.70 expected (-4.9% surprise). Magnisto decodes every CenterPoint Energy (CNP) report into a clear Beat, Miss, In-line or Mixed verdict and checks whether guidance was raised, held or cut.
What is the forecast for CenterPoint Energy (CNP) stock?
Magnisto blends analyst price targets, quantitative research, technical trend and options-implied moves into a scenario range for CenterPoint Energy (CNP), anchored to the current $386.66 share price, so you can weigh the bull, base and bear cases for CenterPoint Energy side by side.
Is CenterPoint Energy (CNP) a buy right now?
Magnisto does not give buy or sell tips. It gives you the institutional-grade evidence — the verdict, valuation, risks, technicals and hedge-fund 13F flows — so you can decide whether CenterPoint Energy fits your own thesis and risk profile. This is research, not investment advice.

Related stocks

Educational research, not investment advice. Figures are illustrative and may be delayed.